Kalaris Therapeutics, Inc. (KLRS)
Nasdaq: KLRS · Biological Products, (No Diagnostic Substances) · Berkeley Heights, NJ · filing with the SEC since 2018
The company now
Kalaris Therapeutics, Inc. is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836), based in Berkeley Heights, NJ. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported a loss of $43 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.